152. PCDH19関連症候群 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 10 / 薬物数 : 7 - (DrugBank : 1) / 標的遺伝子数 : 16 - 標的パスウェイ数 : 7
薬物ごとの開発者(Primary Sponsor)、臨床試験情報(抜粋)です。
CCD 1042, MD 9150000, Mepalon 1042, SPT316
Marinus Pharmaceuticals, Inc
2019 Phase 3 EUCTR2018-004496-12-IT Australia;Belgium;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom;United States;
Marinus Pharmaceuticals, Inc.
2019 Phase 3 EUCTR2018-004496-12-FR Australia;France;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
2015 - EUCTR2015-001324-36-IT Italy;United States;
- Phase 3 EUCTR2018-004496-12-DK Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
CCD 1042, MD 9150000, Mepalon 1042, SPT3162
Marinus Pharmaceuticals, Inc.
2020 Phase 3 EUCTR2018-004496-12-HU Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004496-12-GB Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004496-12-NL Australia;Belgium;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
- Phase 2 EUCTR2018-004496-12-PL Australia;Belgium;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
Ganaxolone
Marinus Pharmaceuticals
2019 Phase 2 NCT03865732 Australia;France;Hungary;Italy;Netherlands;Poland;United States;
2015 Phase 2 NCT02358538 Italy;United States;
Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one)
Marinus Pharmaceuticals, Inc.
2015 - EUCTR2015-001324-36-IT Italy;United States;
Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one)
Marinus Pharmaceuticals, Inc.
2015 - EUCTR2015-001324-36-IT Italy;United States;
Marinus Pharmaceuticals, Inc
2019 Phase 3 EUCTR2018-004496-12-IT Australia;Belgium;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom;United States;
Marinus Pharmaceuticals, Inc.
2019 Phase 3 EUCTR2018-004496-12-FR Australia;France;Hungary;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
2015 - EUCTR2015-001324-36-IT Italy;United States;
- Phase 3 EUCTR2018-004496-12-DK Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
CCD 1042, MD 9150000, Mepalon 1042, SPT3162
Marinus Pharmaceuticals, Inc.
2020 Phase 3 EUCTR2018-004496-12-HU Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004496-12-GB Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;United Kingdom;United States;
2019 Phase 2 EUCTR2018-004496-12-NL Australia;Belgium;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
- Phase 2 EUCTR2018-004496-12-PL Australia;Belgium;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Spain;United Kingdom;United States;
Ganaxolone
Marinus Pharmaceuticals
2019 Phase 2 NCT03865732 Australia;France;Hungary;Italy;Netherlands;Poland;United States;
2015 Phase 2 NCT02358538 Italy;United States;
Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one)
Marinus Pharmaceuticals, Inc.
2015 - EUCTR2015-001324-36-IT Italy;United States;
Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one)
Marinus Pharmaceuticals, Inc.
2015 - EUCTR2015-001324-36-IT Italy;United States;